NCT07314658

Brief Summary

The aim this study is to investigate the effects of time-restricted eating (TRE) on body composition, muscle function and markers of metabolic health of adults over 60 years old. This study will compare different variations of TRE - with and without an additional protein. This study involves attending two study days at the University of Surrey for baseline and end-of-intervention measurement of body composition using a gold-standard dual energy x-ray absorptiometry (DEXA) scan; muscle function using hand grip strength and 30-second sit-to-stand tests; weight. A blood sample will be taken at each study visit to measure markers of lipid and glucose control, and insulin sensitivity. Participants will be randomly allocated to one of four study groups:

  • control group: maintain habitual dietary patterns
  • TRE group: fast for 16 hours overnight, eat between 12-8pm
  • TRE + Protein (AM): fast for 16 hours overnight, eat between 12-8pm; take a 30g plant-based protein supplement in the morning
  • TRE + Protein (PM): fast for 16 hours overnight, eat between 12-8pm; take a 30g plant-based protein supplement in the afternoon Participants will be asked to follow the intervention according to their allocated group for 8 weeks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Dec 2025Jul 2027

First Submitted

Initial submission to the registry

November 26, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 2, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

January 2, 2026

Status Verified

November 1, 2025

Enrollment Period

1.5 years

First QC Date

November 26, 2025

Last Update Submit

December 17, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change from baseline in body composition at 2 months using whole-body dual-energy x-ray absorptiometry (DEXA)

    Measured using whole-body dual-energy x-ray absorptiometry (DEXA) In addition to the above, body composition will also be assessed using Tanita Bioelectrical impedance analysis (BIA). Fat free and fat mass will be reported in kg.

    For 8 weeks of the assigned study intervention

  • Change from baseline in muscle function at 2 months

    Measured using grip strength

    At the start and end of 8 weeks of the assigned study intervention

  • Change from baseline in muscle function at 2 months

    Measured using 30-second sit-to-stand test.

    At the start and end of 8 weeks of the assigned study intervention

Secondary Outcomes (5)

  • Change in fasting glucose control indicators

    At the start and end of 8 weeks of the assigned study intervention

  • Change from baseline in insulin sensitivity at 2 months

    At the start and end of 8 weeks of the assigned study intervention

  • Change from baseline in lipid metabolism at 2 months

    At the start and end of 8 weeks of the assigned study intervention

  • Change from baseline in diet composition at 2 months

    At the start, mid-point (week 4) and end of 8 weeks of the assigned study intervention

  • Feasibility of the assigned TRE intervention

    at the end of the 8 week intervention

Study Arms (4)

TRE

EXPERIMENTAL

Participants undertaking the TRE intervention

Other: TRE

ProtAM TRE

EXPERIMENTAL

Participants undertaking the ProtAM TRE intervention

Other: ProtAM TRE

ProtPM TRE

EXPERIMENTAL

Participants undertaking the ProtPM TRE intervention

Other: ProtPM TRE

Control

NO INTERVENTION

Interventions

* Participants will be asked to follow a 16:8 TRE protocol, consuming all their daily within 8 hours, between 12 and 8pm, and fast for 16 hours overnight. * Outside of the eating window, participants will be allowed to consume energy-free drinks only, i.e. water, black tea/coffee, 0-calorie soft drinks. * In addition, they will be asked to consume a protein drink containing 30g protein in the afternoon, either 2 hours after their first meal or 2 hours before their last meal of the day.

Also known as: TRE + afternoon protein 'snack'
ProtPM TRE
TREOTHER

* Participants will be asked to follow a 16:8 TRE protocol, consuming all their daily within 8 hours, between 12 and 8pm, and fast for 16 hours overnight. * Outside of the eating window, participants will be allowed to consume energy-free drinks only, i.e. water, black tea/coffee, 0-calorie soft drinks.

TRE

* Participants will be asked to follow a 16:8 TRE protocol, consuming all their daily within 8 hours, between 12 and 8pm, and fast for 16 hours overnight. * Outside of the eating window, participants will be allowed to consume energy-free drinks only, i.e. water, black tea/coffee, 0-calorie soft drinks. * In addition, they will be asked to consume a protein drink containing 30g protein in the morning, 2 hours before the 8-hour eating window opens at 12pm (i.e. at 10am).

Also known as: TRE + morning protein 'snack'
ProtAM TRE

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gender: male and female
  • Age range: 60 years or older
  • Fasting for 12 or less hours on a daily basis
  • BMI range: 23-30 kg/m2
  • Weight stability: no more than 3kg weight gain or loss in the past 3 months
  • Regular eating pattern, i.e. 3 meals a day
  • Able to prepare the protein supplement

You may not qualify if:

  • known renal impairment
  • heart attack or stroke in the past three months
  • continuous use of supplemental oxygen to manage a chronic pulmonary condition or heart failure
  • rheumatoid arthritis
  • Parkinson's disease
  • active treatment for cancer in the past year
  • insulin dependent diabetes mellitus
  • taking medications that preclude fasting for 16 h
  • actively trying or planning to lose weight
  • history of an eating disorder
  • outside of stated age or BMI range
  • fasting for longer than 12 hours on a daily basis
  • unable to prepare the protein supplement
  • extreme morning/evening chronotype
  • sleep disorders
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Surrey

Guildford, GU2 7XH, United Kingdom

RECRUITING

MeSH Terms

Interventions

Trehalase

Intervention Hierarchy (Ancestors)

DisaccharidasesGlycoside HydrolasesHydrolasesEnzymesEnzymes and Coenzymes

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2025

First Posted

January 2, 2026

Study Start

December 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

January 2, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Not required or applicable for this study protocol

Locations